Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00HSK
|
|||
| Former ID |
DNCL003166
|
|||
| Drug Name |
Algenpantucel-L
|
|||
| Synonyms |
HyperAcute pancreas (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 3 | [1], [2] | |
| Company |
NewLink Genetics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Galactosyltransferase (GALT) | Target Info | . | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01836432) Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Recent Treatment Advances and Novel Therapies in Pancreas Cancer: A Review. J Gastrointest Cancer. 2014; 45(2): 190-201. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.